← All stocks

Sonoma Pharmaceuticals, Inc.

SNOA Net buying
CIK 0001367083 #5371 in the set updated 22 Sep 2026
Bought (120 mo)
$125.37K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$125.37K
+$125.37K against sales at will

By person

13 insiders · 25 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Miller Robert E
Former CFO
$86.82K (15)
+$86.82K
103,556
$424.54K
+56.3%
Schutz James J
Former CEO and Former Director
$30.24K (8)
+$30.24K
35,858
$147.00K
+451.2%
Umscheid Marc
Chief Strategy/Mkt Officer
$8.30K (2)
+$8.30K
3,392
$13.91K
Thornton Bruce
Executive VP and COO
154,411
$633.02K
+18,616%
Trombly Amy Moss
Chief Executive Officer
153,586
$629.64K
DVONCH JEROME J
Chief Financial Officer
84,595
$346.81K
+172.8%
Birnbaum Jay E
Director
51,659
$211.78K
+958.4%
MCLAUGHLIN JOHN
Director
48,728
$199.77K
+642.1%
Harrison Russell Joseph
Director
46,520
$190.71K
+717.9%
BARBARI SHARON
Director
43,417
$177.99K
+733.5%
Dal Poggetto John
Controller
15,000
$61.49K
Northey Robert Allen
Exe. VP of Research and Dev.
8,082
$33.13K
Edwards Robert Grant
Chief Financial Officer
2,609
$10.70K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 1,339,170 to 4,785,801 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 118
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 602,426
History held since 30 Nov 2016